David N. Cade
Group Chief Medical OfficerDr. David N. Cade, M.D., MBBS, MBA, GAICD, served as Chief Executive Officer of Asia Pacific of Telix Pharmaceuticals Limited since 2021 until December 2023. Dr. Cade was President of APAC of Telix Pharmaceuticals Limited from May 2021 to 2021. Dr. Cade served as the Chief Business Officer and Head of Investor Relations at Telix Pharmaceuticals Limited since October 2019 until May 2021. Dr. Cade had been Chief Medical Officer of Cochlear Ltd since October 2017 until August 2019. Dr. Cade served as Global Medical Director of Sirtex Medical Inc. until September 22, 2017. Dr. Cade served as Chief Medical Officer of Sirtex Medical Limited since 2007 until August 29, 2017. He served as Medical Director for U S Operations of Sirtex Medical Ltd., since March 5, 2006 and served as its Medical Director of Europe. Dr. Cade relocated from Australia to support all aspects of Sirtex Medical Ltd.’s activities, but with an emphasis on clinical affairs. He gained deep experience in the Oncology, Interventional Radiology and Nuclear Medicine therapeutic areas at Sirtex Medical. In his career David trained in surgery at Monash Medical Centre in Melbourne and worked at management consultancy, Booz & Company across the Asia Pacific. Dr. Cade has experience as an industry physician spanning the fields of novel biotechnology, pharmaceuticals and medical devices. He holds Bachelor of Medicine / Bachelor of Surgery (MBBS) from Monash Medical School, Monash University and a Master of Business Administration (MBA) from Melbourne Business School, University of Melbourne and ESADE Business and Law School Barcelona. He is a Graduate of the Australian Institute of Company Directors.
Positions
- Company NameTelix Pharmaceuticals LimitedStock CodeTLXPositionGroup Chief Medical OfficerColleagues
- CPChristian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director
- DNDavid N. GillIndependent Non-Executive Chair of the Board
- DSDarren SmithGroup Chief Financial Officer
- DPDarren PattiGroup Chief Operating Officer
- PSPaul SchafferSVP of Research & Development
- MAMark Alexander NelsonIndependent Non-Executive Director
- JEJann Elizabeth SkinnerIndependent Non-Executive Director
- MEMarie E. McDonaldIndependent Non-Executive Director
